Literature DB >> 3590433

Measurement of the risk of calcium phosphate crystallization in urine.

H G Tiselius.   

Abstract

A method is described for analysis of the risk of calcium phosphate (CaP) crystallization in urine samples. The pH required for formation of 500 crystals in the size range 3.5 to 5 micron (pHCaP) was determined in a Coulter Counter following addition of sodium hydroxide. The risk of CaP crystallization (CaP-CR) was defined as: 1/(pHCaP--5.8). CaP-CR was determined in 24 h urine collections from 25 patients with calcium stone disease and 26 normal subjects, each urine diluted to a creatinine concentration of 5 mumol per ml. The mean (+/- SD) CaP-CR was 0.71 +/- 0.18 and 0.63 +/- 0.14 respectively and did not differ significantly. This method might be useful for evaluations and follow-up of stone formers with respect to the risk of CaP precipitation and stone formation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3590433     DOI: 10.1007/bf00260937

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  6 in total

Review 1.  Inhibitors and promoters of stone formation.

Authors:  H Fleisch
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

2.  A simplified estimate of the ion-activity product of calcium phosphate in urine.

Authors:  H G Tiselius
Journal:  Eur Urol       Date:  1984       Impact factor: 20.096

3.  A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation.

Authors:  M J Nicar; K Hill; C Y Pak
Journal:  Metabolism       Date:  1983-09       Impact factor: 8.694

4.  A biochemical basis for grouping of patients with urolithiasis.

Authors:  H G Tiselius; L E Almgård; L Larsson; B Sörbo
Journal:  Eur Urol       Date:  1978       Impact factor: 20.096

5.  Measurement of the risk of calcium oxalate crystallization in urine.

Authors:  H G Tiselius
Journal:  Urol Res       Date:  1985

6.  Biochemical evaluation of patients with urolithiasis.

Authors:  H G Tiselius; L Larsson
Journal:  Eur Urol       Date:  1981       Impact factor: 20.096

  6 in total
  5 in total

Review 1.  Risk formulas in calcium oxalate urolithiasis.

Authors:  H G Tiselius
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate.

Authors:  C Berg; L Larsson; H G Tiselius
Journal:  Urol Res       Date:  1990

3.  Crystalluria determined by polarization microscopy. Technique and results in healthy control subjects and patients with idiopathic recurrent calcium urolithiasis classified in accordance with calciuria.

Authors:  U Herrmann; P O Schwille; P Kuch
Journal:  Urol Res       Date:  1991

Review 4.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

5.  Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation?

Authors:  H G Tiselius; L Larsson
Journal:  Urol Res       Date:  1993-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.